Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report 2 2016: Improved results for Landshypotek Bank

Landshypotek Bank continues to grow and post improved results. The improved earnings for the first half of 2016 were MSEK 7 not including the net result of financial transactions and MSEK 38 when these items were included.“Our earnings and improved result enable us and give us the vigour to continue to develop the bank into a broader bank for entrepreneurs in farming and forestry and for people living on farms,” says Liza Nyberg, CEO of Landshypotek Bank. Consolidated operating profit for the first half of 2016 amounted to MSEK 203, up MSEK 38 compared with the year-earlier period (MSEK

Invitation to presentation of Recipharm’s interim report for the second quarter 2016 on the 22nd July

Recipharm will publish its interim report for January-June 2016 on 22 July at 07:45 am CET.The company invites investors, analysts and media to a web conference (in English) on 22 July at 10:00 am CET, where CEO Thomas Eldered and CFO Björn Westberg will present and comment on the report as well as answer questions. The report will be available on Recipharm’s website www.recipharm.com/investor-relations from 07:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 22 July. To participate in the web conference, please use the below link:

Invitation to conference call of Hoist Finance’s second quarter 2016 report

Hoist Finance will publish the interim report for the second quarter 2016 on Thursday, 28thof July, 2016, at approximately 08.00 AM (CET). A teleconference for investors, analysts and media will be held at 09.30 AM (CET). Jörgen Olsson, CEO and Pontus Sardal, CFO will present and comment the report. The presentation will be held in English via a telephone conference or audio broadcast at http://www.financialhearings.nu/?160728/hoistfinance. No advance notification is necessary. Dial-in details for the conference call: SE: +46 8 566 426 66 UK: +44 203 008 98 19 US: +1 855 831

JT’S CISCO EXPERTISE REACHES NEW HEIGHTS

JT has become the first provider in the Channel Islands to achieve the coveted 'Advanced Collaboration Architecture Specialisation' recognition from global technology provider Cisco.  This status has been granted to JT in recognition of reaching this specialist level for delivering collaboration solutions to its global clients.JT became a Certified Partner with Cisco 15 years ago and has continued to grow and develop its expertise and solutions in this field.  Mark Stuchfield, JT Global Design Solutions Manager, said: “JT’s Global Enterprise team have fulfilled the new training requirements

Potential farm out of 20% of Kraken to Delek

EnQuest PLC, 18 July 2016Potential farm out of 20% of Kraken to Delek  EnQuest PLC ("EnQuest") is pleased to announce that it is holding discussions with Delek Group Ltd ("Delek") for the sale by EnQuest to one of Delek's subsidiaries of an interest in the Kraken development ("Kraken"). EnQuest confirms that EnQuest and Delek have signed a non-binding memorandum of understanding and are working towards executing binding transaction documents. Delek is today releasing information concerning this negotiation as part of its disclosure obligations with regard to a separate transaction.

Cinnober chosen for major design study

Cinnober has signed an agreement with a major international exchange group to conduct a comprehensive design study for utilizing Cinnober’s technology for real-time clearing for listed derivatives as well as a complete CSD system (Central Security Depository). The tender process has included a profound evaluation of the available global technology providers and Cinnober has now been uniquely selected to commence work while conducting a full design study that should be completed in December. Cinnober has unique experience of providing clearing and risk management solutions to tier one

Diamyd Medical and UCLA advance therapeutic development for type 1 diabetes

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) announced today that Diamyd Medical has agreed to further advance its Antigen Based Technology together with researchers at the University of California, Los Angeles (UCLA). Strong synergistic effects have earlier been reported in an animal model receiving GABA in combination with either GAD65 or proinsulin. This new preclinical study will evaluate if GABA in combination with both autoantigens improves efficacy even further. Diamyd Medical licenses exclusive rights from UCLA for the therapeutic use of GABA alone or in combination

Anders Hägg new CFO for Scandi Standard

Anders Hägg is recruited as new CFO for Nordic chicken producer Scandi Standard. Anders is currently CFO for Arla Foods UK and was previously CFO for Arla Foods in Sweden for 4 years.Anders has extensive experience from senior positions in the food industry. He has been with Arla since 2010. Previously, he was in the Unilever group during 15 years, in several senior positions within finance in different markets and countries. He has an MBA from Gothenburg School of Economics. - With Anders, we get a very competent and internationally merited leader that together with the team will

Magnus Agervald leaves his position as CEO of Byggmax Group AB

Byggmax CEO Magnus Agervald has informed the Board of Directors of Byggmax that he intends to leave his position. The process of finding a new CEO for Byggmax will commence immediately and will be headed by Byggmax Chairman Mr. Anders Moberg.Magnus Agervald became deputy CEO of Byggmax in 2006 and CEO in 2008. Since then, the company from one country to four countries, and from more than SEK 1 billion in turnover, to more than SEK 5 billion. “On behalf of the Board and myself, I am sad to announce that Magnus Agervald has chosen to move on in his career after ten intense and not the

NOTE’s Interim Report January–June 2016

Financial performance April–June• Sales increased by 1% to SEK 282.4 (279.5) million.• Operating profit rose to SEK 15.4 (11.2) million.• Operating margin expanded by 1.5 percentage points to 5.5% (4.0%).• Profit after financial items increased to SEK 13.6 (9.2) million.• Profit after tax up to SEK 11.0 (8.5) million, corresponding to SEK 0.38 (0.29) per share.• Cash flow after investments increased to SEK 4.1 (-18.0) million, or SEK 0.14 (-0.62) per share.Financial performance January–June• Sales increased by 1% to SEK 561.5 (554.8) million.• Operating profit rose to SEK

Magnus Agervald appointed as new CEO of Ratos

This information is information that Ratos AB is obliged to make public pursuant to the EU Market Abuse Regulation.The information was submitted for publication, through the agency of the contact person set out above, on 18 July 2016 at 08:30 CET. The Board of Directors has decided to appoint Magnus Agervald, as the new CEO of Ratos effective January 2017 at the latest. Immediately prior to joining Ratos, Magnus Agervald was President and CEO of the publicly listed Byggmax Group. "The Board has worked intensely to find the right CEO for the next phase in Ratos's development. We are

Enzymatica AB: Excellent volume growth for ColdZyme®

Q2              · Net sales reached SEK 4.9 (3.1) million. · Loss after tax came in at SEK -12.3 (-10.4) thousand. · Earnings per share were SEK -0.20 (-0.42). · Cash and cash equivalents were SEK 26.9 (23.4) thousand Significant events in Q2 · Enzymatica completed its acquisition of Icelandic company Zymetech effective April 1. · Enzymatica completed its new share issue, raising SEK 60 million before issue expenses. H1                       · Net sales increased to SEK 13.3 (10.0) million. · Loss after tax came in at SEK -20.9 (-19.5) million. ·

ASTRAZENECA PLC ANNOUNCES TAGRISSO MET PRIMARY ENDPOINT IN PHASE III 2ND-LINE LUNG CANCER TRIAL

Tagrisso demonstrated superior progression-free survival compared to standard platinum-based chemotherapy, with a safety profile consistent with previous trials First randomised trial to evaluate the clinical benefit of an EGFR T790Mmedicine, and data are consistent with those supporting Tagrisso approvalsThis announcement contains inside information AstraZeneca today announced that the Phase III AURA3 trial met its primary endpoint, demonstrating superior progression-free survival (PFS) compared to standard platinum-based doublet chemotherapy. The AURA3 randomised trial assessed

ASSA ABLOY acquires DemoTeller in the US

ASSA ABLOY has acquired DemoTeller, a leading provider of instant issuance solutions for the financial market in North America. "DemoTeller is an exciting technological addition to the ASSA ABLOY Group. The company complements our current offering within secure issuance solutions. The acquisition of DemoTeller considerably enhances the Group´s position within secure issuance and will provide complementary growth opportunities”, says Johan Molin, President and CEO of ASSA ABLOY. "By acquiring DemoTeller, we increase our strategic advantage to address a growing segment of the secure

Konecranes will deliver six more RTGs to Noatum Container Terminal Valencia in Spain

This will be Konecranes’ fifth RTG delivery to Noatum Container Terminal Valencia in Spain. When the six RTGs on order go into operation, Noatum will operate a fleet of 27 Konecranes RTGs. The order was received in June 2016 and the cranes will be delivered in spring 2017. Noatum Container Terminal Valencia is the main gateway for the Iberian Peninsula and the natural port of Madrid. The main global container shipping lines call at the terminal in Valencia. These services are complemented by feeder connections to other regions. Gustavo Ferrer, Terminal Manager of Noatum, commented: “I

Orkla ASA: Mandatory notification of trade - options

On 15 July, in connection with Orkla's former management option programme, 100,000 options in Orkla-shares were exercised at a strike price of NOK 40.03 per share.After this transaction, the total number of options issued in Orkla shares under the management option programme is 1,205,000. Orkla owns 1,463,135 treasury shares.Orkla ASAOslo, 18 July 2016Ref.:Investor RelationsElise HeidenreichTel.: +47 951 41 147 This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Record quarter for Inwido

This information is such that Inwido AB (publ) is obliged to publish in accordance with the EU Market Abuse Regulation. The information was submitted by the contact persons below for publication on Monday, 18 July 2016 at 7:46 a.m. Inwido’s President and CEO Håkan Jeppsson comments on the second quarter of 2016:“At SEK 208 million (180), we are reporting an operating profit of more than SEK 200 million for an individual quarter for the first time. This was Inwido’s best quarter ever.” “In line with the strong growth in earnings, the operating margin rose to 14.2 percent and sales

Interim report January-June 2016

This information is information that Inwido AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 07:45 on Monday July 18th, 2016. Best quarter to date Second quarter 2016 · Net sales rose to SEK 1,470 million (1,376), an increase of 2 percent for comparable units adjusted for currency effects · Operating EBITA rose to SEK 208 million (180) and operating EBITA margin rose to 14.2 percent (13.1) · EBITA increased to SEK 202

Viennese hospitals to improve cancer treatment with Elekta equipment and software

VIENNA, Austria, July 18, 2016 - The Vienna Hospital Association (Wiener Krankenanstaltenverbund) has chosen to treat its cancer patients with advanced solutions from Elekta’s (EKTA-B.ST) radiation therapy and software portfolio. The deal will include four Versa HD and two Elekta Infinity linear accelerators, brachytherapy afterloaders, MOSAIQ oncology information system and Monaco treatment planning system, as well as long-term service contracts.The equipment and software will be installed at two new radiation oncology departments situated in Vienna: Hietzing Hospital (KHR) and

Notice Pursuant to the Finnish Securities Market Act, Chapter 9, Section 5

ELISA STOCK EXCHANGE RELEASE 18 JULY 2016 AT 08:30 AM Elisa Corporation (ELISA) has received the following notice in accordance with Chapter 9, Section 5 of the Finnish Securities Market Act: According to the notification, the direct share ownership of Elisa Corporation shares owned by BlackRock, Inc. and its funds decreased on 14 July 2016 below five (5) per cent of Elisa Corporation’s entire stock while total ownership directly or through financial instruments remains above 5 per cent. Total number of Elisa shares is 167,335,073 and each share carries one voting right. Total

Opera Software ASA – Detailed Announcement

Oslo, 18 July 2016 Reference is made to the stock exchange announcement made on 15 March 2016 on the launch of the voluntary cash offer (the “Public Offer”) to acquire 100% of the shares of Opera Software ASA (“Opera”) made by Kunqi (the “Offeror”). Termination of the Public Offer and agreement on alternative transaction regarding sale of certain parts of Opera’s consumer business The conditions to close the Public Offer stipulated in the offer document were not met by the drop-dead date of 15 July 2016. As a condition for entering into the alternative transaction described below,

Vision Research Unveils the Phantom VEO® Family of High-Speed Cameras

Compact and Rugged, Phantom VEO Offers the Ultimate in Size, Speed and Resolution for a Wide Range of Scientific and Industrial Applications Contact: Kyle Kappmeier +1 908-722-5757, kkappmeier@randjsc.com WAYNE, NJ –Vision Research, a leading manufacturer of digital high‑speed imaging systems, today added further depth to its high-speed camera lineup with the debut of its new Phantom VEO® product family. Designed for a wide-range of applications including scientific analysis, material testing and defense research, Phantom VEO cameras offer the unchallenged performance of the renowned

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Hawaii

Free youth baseball clinic to feature Albie Lopéz, Ron Robinson and other MLB AlumniColorado Springs, Colo. – Local youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series. In partnership with Chevy Youth Baseball, the free clinics will feature former Indians teammates Albie Lopéz and Rene Gonzales, as well as left-handed pitcher Onan Masaoka, Hawaii native Joey Meyer, right-handed pitcher Glenn Mickens, nine-year MLB veteran Ron Robinson and right-handed pitcher Tyler Yates.

There are no items matching the current filter
There are no more items matching the current filter
Back to top